# Deere & Co: financial statements, quarterly

DE · NYSE · CIK 315189 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 1

Pages: [Overview](/companies/de.md) · [Financials](/companies/de/financials.md) · [Filings](/companies/de/filings.md) · [Insiders](/companies/de/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/de/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-29) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q4 FY2024 (2024-10-27) | Q1 FY2025 (2025-01-26) | Q2 FY2025 (2025-04-27) | Q3 FY2025 (2025-07-27) | Q4 FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [15.4 d](/filings/0001104659-25-122321.md) | [12.2](/filings/0001558370-25-001714.md) | [15.2](/filings/0001558370-25-008218.md) | [13.2](/filings/0001558370-25-011789.md) | [11.1 d](/filings/0001104659-25-122321.md) | [8.5](/filings/0001104659-26-020158.md) | [12.8](/filings/0001104659-26-067311.md) | [12.0](/filings/0001104659-26-102213.md) | [12.4 d](/filings/0001104659-25-122321.md) | [9.6](/filings/0001104659-26-020158.md) | [13.4](/filings/0001104659-26-067311.md) | [12.6](/filings/0001104659-26-102213.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $bn | [0.6 d](/filings/0001104659-25-122321.md) | [0.5](/filings/0001558370-25-001714.md) | [0.6](/filings/0001558370-25-008218.md) | [0.6](/filings/0001558370-25-011789.md) | [0.6 d](/filings/0001104659-25-122321.md) | [0.5](/filings/0001104659-26-020158.md) | [0.5](/filings/0001104659-26-067311.md) | [0.6](/filings/0001104659-26-102213.md) | [0.7 d](/filings/0001104659-25-122321.md) | [0.6](/filings/0001104659-26-020158.md) | [0.6](/filings/0001104659-26-067311.md) | [0.6](/filings/0001104659-26-102213.md) |
| Selling, general and administrative | $bn | [1.2 d](/filings/0001104659-25-122321.md) | [1.1](/filings/0001558370-25-001714.md) | [1.3](/filings/0001558370-25-008218.md) | [1.3](/filings/0001558370-25-011789.md) | [1.2 d](/filings/0001104659-25-122321.md) | [1.0](/filings/0001104659-26-020158.md) | [1.2](/filings/0001104659-26-067311.md) | [1.2](/filings/0001104659-26-102213.md) | [1.3 d](/filings/0001104659-25-122321.md) | [1.0](/filings/0001104659-26-020158.md) | [1.2](/filings/0001104659-26-067311.md) | [1.2](/filings/0001104659-26-102213.md) |
| Operating income | $bn | [3.0 d](/filings/0001558370-24-016169.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $bn | [0.8 d](/filings/0001104659-25-122321.md) | [0.8](/filings/0001558370-25-001714.md) | [0.8](/filings/0001558370-25-008218.md) | [0.8](/filings/0001558370-25-011789.md) | [0.9 d](/filings/0001104659-25-122321.md) | [0.8](/filings/0001104659-26-020158.md) | [0.8](/filings/0001104659-26-067311.md) | [0.8](/filings/0001104659-26-102213.md) | [0.8 d](/filings/0001104659-25-122321.md) | [0.7](/filings/0001104659-26-020158.md) | [0.7](/filings/0001104659-26-067311.md) | [0.7](/filings/0001104659-26-102213.md) |
| Income tax | $bn | [0.7 d](/filings/0001104659-25-122321.md) | [0.5](/filings/0001558370-25-001714.md) | [0.8](/filings/0001558370-25-008218.md) | [0.6](/filings/0001558370-25-011789.md) | [0.2 d](/filings/0001104659-25-122321.md) | [0.0](/filings/0001104659-26-020158.md) | [0.5](/filings/0001104659-26-067311.md) | [0.3](/filings/0001104659-26-102213.md) | [0.4 d](/filings/0001104659-25-122321.md) | [0.2](/filings/0001104659-26-020158.md) | [0.5](/filings/0001104659-26-067311.md) | [0.5](/filings/0001104659-26-102213.md) |
| Net income | $bn | [2.4 d](/filings/0001104659-25-122321.md) | [1.8](/filings/0001558370-25-001714.md) | [2.4](/filings/0001558370-25-008218.md) | [1.7](/filings/0001558370-25-011789.md) | [1.2 d](/filings/0001104659-25-122321.md) | [0.9](/filings/0001104659-26-020158.md) | [1.8](/filings/0001104659-26-067311.md) | [1.3](/filings/0001104659-26-102213.md) | [1.1 d](/filings/0001104659-25-122321.md) | [0.7](/filings/0001104659-26-020158.md) | [1.8](/filings/0001104659-26-067311.md) | [1.4](/filings/0001104659-26-102213.md) |
| Diluted EPS | $ per share | not reported | [6.23](/filings/0001558370-25-001714.md) | [8.53](/filings/0001558370-25-008218.md) | [6.29](/filings/0001558370-25-011789.md) | not reported | [3.19](/filings/0001104659-26-020158.md) | [6.64](/filings/0001104659-26-067311.md) | [4.75](/filings/0001104659-26-102213.md) | not reported | [2.42](/filings/0001104659-26-020158.md) | [6.55](/filings/0001104659-26-067311.md) | [5.10](/filings/0001104659-26-102213.md) |
| Basic EPS | $ per share | not reported | [6.25](/filings/0001558370-25-001714.md) | [8.56](/filings/0001558370-25-008218.md) | [6.32](/filings/0001558370-25-011789.md) | not reported | [3.20](/filings/0001104659-26-020158.md) | [6.65](/filings/0001104659-26-067311.md) | [4.76](/filings/0001104659-26-102213.md) | not reported | [2.43](/filings/0001104659-26-020158.md) | [6.57](/filings/0001104659-26-067311.md) | [5.11](/filings/0001104659-26-102213.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-29) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | FY2024 (2024-10-27) | Q1 FY2025 (2025-01-26) | Q2 FY2025 (2025-04-27) | Q3 FY2025 (2025-07-27) | FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.5](/filings/0001104659-25-122321.md) | [5.1](/filings/0001558370-25-001714.md) | [5.6](/filings/0001558370-25-008218.md) | [7.0](/filings/0001558370-25-011789.md) | [7.3](/filings/0001104659-25-122321.md) | [6.6](/filings/0001104659-26-020158.md) | [8.0](/filings/0001104659-26-067311.md) | [8.6](/filings/0001104659-26-102213.md) | [8.3](/filings/0001104659-26-102213.md) | [6.8](/filings/0001104659-26-020158.md) | [7.9](/filings/0001104659-26-067311.md) | [8.9](/filings/0001104659-26-102213.md) |
| Total assets | $bn | [104](/filings/0001104659-25-122321.md) | [101](/filings/0001558370-25-001714.md) | [106](/filings/0001558370-25-008218.md) | [108](/filings/0001558370-25-011789.md) | [107](/filings/0001104659-25-122321.md) | [103](/filings/0001104659-26-020158.md) | [106](/filings/0001104659-26-067311.md) | [108](/filings/0001104659-26-102213.md) | [106](/filings/0001104659-26-102213.md) | [103](/filings/0001104659-26-020158.md) | [107](/filings/0001104659-26-067311.md) | [108](/filings/0001104659-26-102213.md) |
| Total liabilities | $bn | [82.2](/filings/0001558370-24-016169.md) | [79.2](/filings/0001558370-25-001714.md) | [82.8](/filings/0001558370-25-008218.md) | [84.7](/filings/0001558370-25-011789.md) | [84.4](/filings/0001104659-25-122321.md) | [80.6](/filings/0001104659-26-020158.md) | [81.9](/filings/0001104659-26-067311.md) | [82.6](/filings/0001104659-26-102213.md) | [80.0](/filings/0001104659-26-102213.md) | [77.1](/filings/0001104659-26-020158.md) | [79.5](/filings/0001104659-26-067311.md) | [79.6](/filings/0001104659-26-102213.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [17.9](/filings/0001558370-24-016169.md) | [17.1](/filings/0001558370-25-001714.md) | [17.7](/filings/0001558370-25-008218.md) | [15.3](/filings/0001558370-25-011789.md) | [13.5](/filings/0001104659-25-122321.md) | [12.8](/filings/0001104659-26-020158.md) | [15.9](/filings/0001104659-26-067311.md) | [14.6](/filings/0001104659-26-102213.md) | [13.8](/filings/0001104659-26-102213.md) | [14.4](/filings/0001104659-26-020158.md) | [15.6](/filings/0001104659-26-067311.md) | [17.1](/filings/0001104659-26-102213.md) |
| Shareholders' equity | $bn | [21.8](/filings/0001558370-24-016169.md) | [22.1](/filings/0001558370-25-001714.md) | [22.7](/filings/0001558370-25-008218.md) | [23.1](/filings/0001558370-25-011789.md) | [22.8](/filings/0001104659-25-122321.md) | [22.5](/filings/0001104659-26-020158.md) | [24.3](/filings/0001104659-26-067311.md) | [25.2](/filings/0001104659-26-102213.md) | [26.0](/filings/0001104659-26-102213.md) | [26.3](/filings/0001104659-26-020158.md) | [27.4](/filings/0001104659-26-067311.md) | [28.0](/filings/0001104659-26-102213.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-29) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q4 FY2024 (2024-10-27) | Q1 FY2025 (2025-01-26) | Q2 FY2025 (2025-04-27) | Q3 FY2025 (2025-07-27) | Q4 FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5,693 d](/filings/0001104659-25-122321.md) | [(908)](/filings/0001558370-25-001714.md) | [1,852 d](/filings/0001558370-25-008218.md) | [3,195 d](/filings/0001558370-25-011789.md) | [5,092 d](/filings/0001104659-25-122321.md) | [(1,132)](/filings/0001104659-26-020158.md) | [1,700 d](/filings/0001104659-26-067311.md) | [2,896 d](/filings/0001104659-26-102213.md) | [3,995 d](/filings/0001104659-25-122321.md) | [(890)](/filings/0001104659-26-020158.md) | [1,932 d](/filings/0001104659-26-067311.md) | [2,208 d](/filings/0001104659-26-102213.md) |
| Capital expenditure | $m | [611 d](/filings/0001104659-25-122321.md) | [362](/filings/0001558370-25-001714.md) | [357 d](/filings/0001558370-25-008218.md) | [324 d](/filings/0001558370-25-011789.md) | [597 d](/filings/0001104659-25-122321.md) | [352](/filings/0001104659-26-020158.md) | [203 d](/filings/0001104659-26-067311.md) | [297 d](/filings/0001104659-26-102213.md) | [508 d](/filings/0001104659-25-122321.md) | [256](/filings/0001104659-26-020158.md) | [195 d](/filings/0001104659-26-067311.md) | [265 d](/filings/0001104659-26-102213.md) |
| Dividends paid | $m | [362 d](/filings/0001104659-25-122321.md) | [386](/filings/0001558370-25-001714.md) | [410 d](/filings/0001558370-25-008218.md) | [406 d](/filings/0001558370-25-011789.md) | [403 d](/filings/0001104659-25-122321.md) | [403](/filings/0001104659-26-020158.md) | [440 d](/filings/0001104659-26-067311.md) | [439 d](/filings/0001104659-26-102213.md) | [438 d](/filings/0001104659-25-122321.md) | [441](/filings/0001104659-26-020158.md) | [437 d](/filings/0001104659-26-067311.md) | [438 d](/filings/0001104659-26-102213.md) |
| Share repurchases | $m | [2,553 d](/filings/0001104659-25-122321.md) | [1,328](/filings/0001558370-25-001714.md) | [1,094 d](/filings/0001558370-25-008218.md) | [805 d](/filings/0001558370-25-011789.md) | [780 d](/filings/0001104659-25-122321.md) | [441](/filings/0001104659-26-020158.md) | [397 d](/filings/0001104659-26-067311.md) | [298 d](/filings/0001104659-26-102213.md) | [2.0 d](/filings/0001104659-25-122321.md) | [302](/filings/0001104659-26-020158.md) | [198 d](/filings/0001104659-26-067311.md) | [197 d](/filings/0001104659-26-102213.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-29) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-30) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q1 FY2025 (2025-01-26) | Q2 FY2025 (2025-04-27) | Q3 FY2025 (2025-07-27) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [299](/filings/0001558370-24-002149.md) | [297](/filings/0001558370-24-008770.md) | [292](/filings/0001558370-24-012529.md) | [281](/filings/0001558370-25-001714.md) | [278](/filings/0001558370-25-008218.md) | [276](/filings/0001558370-25-011789.md) | [272](/filings/0001104659-26-020158.md) | [272](/filings/0001104659-26-067311.md) | [271](/filings/0001104659-26-102213.md) | [271](/filings/0001104659-26-020158.md) | [271](/filings/0001104659-26-067311.md) | [271](/filings/0001104659-26-102213.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 269,625,412 at 2026-08-02, from the cover of the [10-Q filed 2026-08-27](/filings/0001104659-26-102213.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.